Butcher Nancy J, Monsour Andrea, Mew Emma J, Szatmari Peter, Pierro Agostino, Kelly Lauren E, Farid-Kapadia Mufiza, Chee-A-Tow Alyssandra, Saeed Leena, Monga Suneeta, Ungar Wendy, Terwee Caroline B, Vohra Sunita, Fergusson Dean, Askie Lisa M, Williamson Paula R, Chan An-Wen, Moher David, Offringa Martin
Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada.
Department of Psychiatry, The Hospital for Sick Children, Toronto, Canada.
Trials. 2019 Mar 6;20(1):161. doi: 10.1186/s13063-019-3248-0.
Inadequate and poor quality outcome reporting in clinical trials is a well-documented problem that impedes the ability of researchers to evaluate, replicate, synthesize, and build upon study findings and impacts evidence-based decision-making by patients, clinicians, and policy-makers. To facilitate harmonized and transparent reporting of outcomes in trial protocols and published reports, the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT) is being developed. The final product will provide unique InsPECT extensions to the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) and CONSORT (Consolidated Standards of Reporting Trials) reporting guidelines.
The InsPECT SPIRIT and CONSORT extensions will be developed in accordance with the methodological framework created by the EQUATOR (Enhancing the Quality and Transparency of Health Research Quality) Network for reporting guideline development. Development will consist of (1) the creation of an initial list of candidate outcome reporting items synthesized from expert consultations and a scoping review of existing guidance for reporting outcomes in trial protocols and reports; (2) a three-round international Delphi study to identify additional candidate items and assess candidate item importance on a 9-point Likert scale, completed by stakeholders such as trial report and protocol authors, systematic review authors, biostatisticians and epidemiologists, reporting guideline developers, clinicians, journal editors, and research ethics board representatives; and (3) an in-person expert consensus meeting to finalize the set of essential outcome reporting items for trial protocols and reports, respectively. The consensus meeting discussions will be independently facilitated and informed by the empirical evidence identified in the primary literature and through the opinions (aggregate rankings and comments) collected via the Delphi study. An integrated knowledge translation approach will be used throughout InsPECT development to facilitate implementation and dissemination, in addition to standard post-development activities.
InsPECT will provide evidence-informed and consensus-based standards focused on outcome reporting in clinical trials that can be applied across diverse disease areas, study populations, and outcomes. InsPECT will support the standardization of trial outcome reporting, which will maximize trial usability, reduce bias, foster trial replication, improve trial design and execution, and ultimately reduce research waste and help improve patient outcomes.
临床试验中结果报告不充分且质量不佳是一个有充分文献记载的问题,这阻碍了研究人员评估、复制、综合和基于研究结果进行拓展的能力,并影响患者、临床医生和政策制定者基于证据的决策。为促进在试验方案和已发表报告中对结果进行统一和透明的报告,正在开发临床试验计划终点报告工具(InsPECT)。最终产品将为SPIRIT(标准方案项目:干预性试验建议)和CONSORT(报告试验的统一标准)报告指南提供独特的InsPECT扩展。
InsPECT对SPIRIT和CONSORT的扩展将根据EQUATOR(提高卫生研究质量和透明度)网络为报告指南制定创建的方法框架来开发。开发将包括:(1)创建一份候选结果报告项目的初始清单,该清单综合了专家咨询意见以及对试验方案和报告中结果报告现有指南的范围审查;(2)三轮国际德尔菲研究,以识别其他候选项目,并由试验报告和方案作者、系统评价作者、生物统计学家和流行病学家、报告指南开发者、临床医生、期刊编辑和研究伦理委员会代表等利益相关者对候选项目的重要性进行9分制李克特量表评估;(3)一次面对面的专家共识会议,分别确定试验方案和报告的基本结果报告项目集。共识会议的讨论将由独立人员主持,并以在主要文献中确定的实证证据以及通过德尔菲研究收集的意见(综合排名和评论)为依据。除了标准的开发后活动外,在InsPECT开发过程中将采用综合知识转化方法,以促进实施和传播。
InsPECT将提供基于证据且经共识达成的标准,重点关注临床试验中的结果报告,这些标准可应用于不同的疾病领域、研究人群和结果。InsPECT将支持试验结果报告的标准化,这将最大限度地提高试验的可用性、减少偏差、促进试验复制、改善试验设计和执行,并最终减少研究浪费并有助于改善患者结局。